Introduction rphe emergence of antimicrobial resistance in the community J. setting and cost-containment efforts in medicine cany substantial implications on the treatment of community acquired infections.' Current regimens should not only be appropriate in terms of antibacterial spectrum, efficacy, and safety, but should be least expensive and least likely to promote antimicrobial resistance.Â zithromycin is an azalide that is active against streptococci, staphylococci. Haemophilusspp.. Moraxellaspp., Neisseriagonorrhoeae, Chlamydia spp.. and Mycopiasma spp.^ Its broad spectrum, favorable safety prolile. and convenience of use make it an attractive drug for treating community-acquired infections, especially acute respiratory Infections (ARI). However, these advantages are offset by emergence of macrolide resistance and its higher cost. Therefore, auditing and benchmarking azithromycin use may be of great value. Appropriateness of antibiotic therapy (AAT) in the primaiy care setting has been audited to date while focusing on specific syndromes or settings rather than antimicrobials. Despite widespread azithromycin use in the last decade, to our knowledge, no audit has targeted this drug specifically. Moreover, there are only a few data regarding AAT and educational interventions in the military setting. We therefore studied azithromycin use in primary care military clinics with the aim of assessing AAT and performing benchmarking, if necessary.
Materials and Methods

Setting
This cross-sectional study was conducted in three primary care military clinics of the Israeli Defense Forces (IDF), located in basic training compounds across Israel. Of trainee and staiT populations, >95% are ages 18 to 21 years and roughly twothirds are men. Medical care at each base clinic is provided by four to six general physicians (GPs) 24 hours/day. GPs are a heterogeneous population comprised of local and foreign medical school graduates with varying experience, but none are board-certified specialists. GPs are either military medical officers or civilians employed by the military, representative of GPs stationed in other IDF clinics in terms of skills.
The oral antibiotic formulary in IDF clinics inciudes: penicillin V, amoxicillin. erythromycin. azithromycin. trimethoprim sulfamethoxazole. nitrofurantoin. cloxacillin, and minocycline and is neither restricted nor audited. Azithromycin was added to the formulary 4 years before beginning of the study.
Data Collection
All IDF clinics utilize an electronic clinical patient record and. therefore, a complete database is available for all medical encounters and is suitable for surveillance of antibiotic use in primaiy health care.-" All variables were collected both at the clinic level as well as the entire IDF medical service level (when applicable).
We measured the total number of patient visits and visits due to diagnoses for which azithromycin may have been prescribed. Diagnoses (relating to the latter) were grouped according to IDF Medical Corps codes and included: sinusitis, upper respiratory tract infection (URTI). lower respiratory tract infection (LRTI). asthma, other respiratory disorders, ear disorders, and male genital disorders. Because Intemational Classification of Diseases (9th Revision. Clinical Modification (ICD-9)) codes were not used during the study period, encounters pertaining to infection-related diagnosis groups may have also represented noninfectious disorders (e.g., visits for asthma not involving an acute exacerbation or visits for earache not caused by infectious Auditing Azithromycin Use in Prtmary Care Military Clinics otitis). Nevertheless, we assumed that this heterogeneity has ocfunred at a similar frequency at both clinic and IDF levels and during 2003 to 2004.
The aggregate of the above-mentioned infection-related diagnosis (IRD) groups comprised the "population at risk" for antimicrobial prescription, serving as the denominator for calculating the prevalence of each IRD and measurement of antimicrobial consumption normalized to 1.000 visits. We were unable to set 1.000 Inhabitant days as the denominator for consumption as performed elsewhere^ in light of fluctuations in the size of populations stationed in military bases.
We collected data regarding the consumption of antimicrobials that may have been used interchangeably with azithromycin. including penicillin V. amoxicillin. and erythromycin. Antimicrobials whose primary indications are urinary tract [trimethoprim-sulfamethoxa7X)le, nitroflirantoin) or skin infection [cloxacillin. minocycline) were excluded. For antimicrobial consumption, the numerator was the number of defined daily doses [number ODD), calculated as the ntimber of dispensed tablets/capsules, multiplied by number of grams per unit and divided by DDD in grams, according to the World Health Organization Collaborating Centre for Drug Statistics Methodology Index-JOl subclass.^ We verified our observation using the number of prescribed antimicrobial courses as the numerator, normalized to 100 visits at risk [clinic level only). For calculating the economic expenditure, costs were derived from the IDF Pharmaceutical Service and expressed as local currency (exchange rate -1 U.S. dollar = 4.5 New Israeli shekels [NIS)).
Assessment of Appropriateness of Therapy
We identiiied all visits in which azithromycin was prescribed, records were retrieved and categorized per ICD-9. AAT was evaluated visit by visit by two investigators independently [U. Kopylov and J. Gilad). Interobserver variability was <5%. Discordant cases were reviewed by a third author (A. Borer). The criteria used for AAT were based on antibiotic guides and official guidelines.^"'Â AT was assessed by allocation into one of four AAT categories: [1) complete agreement with all components of therapyappropriate use; (2) agreement with chosen agent but therapy is pharmacologically inappropriate [dose, dosing interval, duration of therapy); (3) therapy indicated but chosen agent inappropriate (in relation to diagnosis, severity of illness, safety. cost); and [4) therapy is not indicated. The sum of AAT categories 1 and 2 represented a correct choice of azithromycin.
Study Design and Intervention Protoeol
A preintervention audit was performed between July 1. 2003 and December 31, 2003 [period 1). Clinic GPs were unaware of the entire auditing process during this period to prevent a Hawthorne effect. Since suhstantial rates of inappropriate azithromycin prescription were detected during period 1, we devised a local guideline for benchmarking its use.
The following indications for azithromycin were allowed: [1) first-line therapy for acute nongonococcal urethritis in males; (2) acceptable first-line therapy for serologically proven pertussis; [3] acceptable first-line therapy for community acquired pneumonia; (4) first-line therapy for acute tonsillitis in penicillin allergic patients; (5) first-line therapy for acute sinusitis in penicillin allergic patients; (6) second-line therapy for acute otitis media after failure of amoxicillin: and [7) second-line therapy for acute exacerbation of chronic obstructive pulmonary disease. Recommended doses, dosing interval, and treatment duration were specified per indication. The guideline focused on azithromycin. but prudent use of antibiotics was also emphasized.
The guideline was disseminated to all study clinic GPs by oral presentation, e-mail, and a user-friendly handout. Deviation from the guideline was not allowed, unless approval was sought hy telephone consultation with the investigators. Prescription orders were not reviewed before filled. Should unapproved deviations be detected at a later stage, an educational corrective action was taken toward the responsible GP. Further intervention was not performed owing to limited resources.
The results of intervention were assessed in the respective period July 1. 2004 to Decemher 31. 2004 [period 2) to control {"or seasonal variability. The impact of intervention was measured at the clinic level by comparing periods 1 and 2. Data at the IDF level were used to represent actual trends in expenditure at the entire IDF medical service, without intervention (control).
Statistical Analysis
We compared all variables between the periods 1 and 2 at the study clinic level and the IDF level [when applicable). Statistical analysis was performed using Epilnfo 2004 (Centers for Disease Control and Prevention, Atlanta. GA). We estimated that to demonstrate a significant reduction of at least 25% in Lhe rate of inappropriate therapy between periods (95% confidence. 80% power), a postintervention sample of 30 cases is needed. The xâ nd Fisher's exact tests were used for categorical variables, as appropriate. A p < 0.05 was considered statistically significant. Odds ratios (ORs) are presented for significant categorical variables. Differences in consumption and economic expenditure were expressed as percent change.
Results
Infectious Morbidity
During periods 1 and 2. respectively, there were 46.380 and 37.371 visits in the study clinics, of which 5.818 (12.5%) and 5.259 (14.1%). respectively, were due to IRD (p < 0.0001, OR = 1.14). comprising the population at risk for azithromycin therapy. During the respective periods, there were 701.970 and 701,906 visits in the entire IDF. of which 20.7% and 14.1%. respectively, were due to IRD [p < 0,0001. OR ^ 0.63). The distribution of IRD at the clinic and IDF levels in both periods is presented in Table I . The observed difference was not expected to impact results since all data were adjusted to visits at risk.
Appropriateness of Antibiotic Therapy
During periods 1 and 2, there were 105 and 31 visits in which azithromycin was prescribed and for which complete data were available. The distribution of infectious diagnoses in both periods is presented in tonsillitis and community acquired pneumonia among patients administered azithromycin in period 2.
During period 1. azithromycin therapy was deemed completely appropriate (category I) in only 5.7% of cases. In 3.8%. an alternative agent could have been chosen (category 3). all due to cost considerations. Antimicrobial therapy was deemed unnecessary (category 4) in 90.5% of cases, of^ which 7.4% were also pharmacologically inappropriate [category 2). Following intervention, the frequency of cases allocated to category 1 increased from 5.7% to 41.9% {p < 0,0001, OR = 12) and those allocated to category 4 decreased from 90.5% to 16.2% [p < 0.0001, OR = 0.02). There was an increase in the rate of cases allocated to category 2 (6.7% vs. 29%. p < 0.0007, OR = 5.7) and category 3 [3.8% vs, 12.9%. p = 0.08). Of those allocated to category 3 in period 2. half were due to cost considerations whereas the other half were owing to diagnostic considerations [wrong drug for a particular indication). Thus, azithromycin was correctly chosen in 70.9% of cases postintervention as compared to only 5.7% of cases preintervention (p < 0.00001. OR = 40.3), Inappropriate azithromycin use at the clinic level during period 1 resulted in an excess of economic expenditure of 3.934 NIS. Assuming a similar rate of inappropriate therapy at the entire IDF level, the extrapolated excess economic expenditure on azithromycin in the IDF was calculated to be 420,000 NIS/ year.
Antimicrobial Consumption and Economic Expenditure
Antimicrobial consumption is presented in Table 111 , At the clinic level, there was a substantial decrease in azithromycin consumption but amoxicillin consumption increased by 45% and total consumption hy 15%. When antimicrobial consumption at the clinic level was measured as numher of courses per 100 visits at risk, a similar trend was found; azithromycin consumption decreased by 73% (3 vs. 0,8 courses/100 visits), that of erythromycin was unchanged, and that of penicillin V and amoxicillin increased by 5% [6 vs. 6.3 courses/100 visits) and 60% (5 vs. 8 courses/100 visits), respectively. Overall consumption increased by 4.5% between periods [15.3 vs. 16 courses/ 100 visits).
At the IDF level during the corresponding periods, there was an increase in azithromycin consumption by U.1% and a marked increase in penicillin V and amoxicillin consumption, while erythromycin consumption decreased. Total consumption increased by 20.7% [attributable percent difference bet\veen clinic and IDF levels. -5.7%.).
As shown in Table IV . economic expenditure on study agents decreased by 30% at the clinic level but increased by 2,2% at the IDF level (attributable percent difference. +32.2%). The adjusted economic expenditure decreased from 1,737 to 1,353 NIS/1.000 visits [percent change. -22,1%) at the clinic level hut increased from 3.433 to 3.979 NIS/1.000 \asits (percent change of +16%) at the IDF level. Therefore, the attributable effect of intervention on overall economic expenditure was a percentchange difference of -38.1%.
During period 1. azithromycin consumption at the clinics accounted for 41.6% of antimicrobial-related costs, hut only 15.4% of costs during period 2. while at the IDF level, azithromycin consumption accounted for 43.4% and 41.8% of overall economic expenditure on study antimicrobials, respectively. Therefore, most of the decreased economic expenditure at the clinic level could be attributed to decreased azithromycin utilization. 
Discussion
This study evaluated MT of azithromycin in military primary care. We found that azithromycin has been commonly prescribed inappropriately, leading to suboptimal quality of care and excess expenditure. Inappropriate prescribing was attributed to unnecessary therapy, inappropriate choice of agents, and pharmacological Inappropriateness.
The vast majority of patients treated with azithromycin in this study were those with ARI (85% and 87% in periods 1 and 2). This was not unexpected, given that ARI is the single most common infectious disease among outpatients and the most common infection for which antimicrobials are prescribed in the community. ' •' ' ARI (particularly URTI and bronchitis) are caused by vimses and are a leading cause of inappropriate antimicrobial use.'^ Preintervention. URTI. and acute bronchitis comprised 66.6% of patients given azithromycin. Inappropriate prescribing for these conditions (up to 55% of cases) has been consistently demonstrated worldwide, leading to immense costs.'^'^•'' AAT in our study was assessed by appropriateness categories, a method rarely used to date. We found an exceptionally high rate of unnecessary therapy in period 1 that significantly decreased following intervention. Jelinski et al.^ have also categorized appropriateness, albeit differently: therapy was deemed appropriate (correct choice of drug) in 60.5% and unnecessary in 10.4%. Whereas our study did not have suf ficient power to assess AAT by syndrome (only 136 cases treated with azithromycin in both periods). Jelinski et al.^'' have demonstrated that unnecessary therapy was significantly more common in ARI than non-ARI cases (17% vs. 0.9%). However, they did not address any particular agent. Another study using AAT categories (in the hospifal setting) has found an appropriateness rate of 64%.^^ The most common cause for inappropriateness was unnecessary therapy (64% of cases).
Our study shows that azithromycin is commonly prescribed by military primary care physicians in Israel and that its consumption is twice that of erythromycin. Moreover, azithromycin consumption in the entire IDF has increased hy 11% between 2003 and 2004. a similar trend to that observed in the IDF in the preceding 2 years (data not shown). This trend was coupled with an overall increased consumption of antimicrobials. Due to its higher cost, azithromycin comprised >40% of overall expenditure on studied agents and. therefore, benchmarking of azithromycin was expected to have the greatest effect on overall economic expenditure, according to the Pareto principle.
Surprisingly, studies dealing with aniimicrohial consumption in the community have measured overall macrolide use without reference to new generation agents.^^'^^ This is also true for studies that evaluated consumption with the aim of correlating community antimicrobial use and emergence of resistance.-' Only one study measured azithromycin specifically, but unfortunately, azithromycin accounted for only 4% of prescriptions in the studied setting.^Ô nly a limited number of studies have specifically examined pharmacological aspects of AAT, demonstrating inappropriateness rates of 30% to 90% in relation to dosage^^ or duration of therapy.""^^ In our study, the rate of pharmacological inappropriateness of azithromycin was 7% in period 1 and 29% following intervention, despite that the recommended dose and duration were circulated to GPs. Bearing in mind (Jiat inappropriate dosing or dosing interval may lead to reduced cure rates or excess expenditure, the pharmacological aspects of antimicrobial therapy should receive more emphasis in future interventions.
We performed a limited educational intervention which successftiUy increased AAT and decreased unnecessary therapy, leading to a reduction of azithromycin consumption and related economic expenditure, despite its increased consumption in the entire IDF (attributable percent change of -82%). Nonetheless. an increase of 15% in total antibiotic consumption occurred, which can be attributed to an increase in amoxicillin consumption. Therefore, although our inter\'ention was highly successful in improving azithromycin use and reducing costs (adjusted attributable percent change of expenditure. -38.1%), its effect on overall utilization was quite modest, and it can be speculated that GPs substituted amoxiciilin for azithromycin instead of withholding unnecessary antimicrobial use when indicated.
Numerous intervention modalities have been used with the aim of improving antimicrobial prescription in the community setting with varying success, in part due to highly variable methodological quality. Single interventions that rely on MiUtarv Medicine. Voi. 172. October 2007 guideline formulation (such as in our study), physician education, or feedback reports have not necessarily been successful.
•'""•'"' mainly due to low acceptability by practitioners. On the other hand, multifaceted approaches are far more effective in changing behavior.^^-^^ as evidenced by randomized, controlled trials that have evaluated focus groups of GPs and/or patients.^^^' development of clinical guidelines in collaboration with GPs.-^'' production of education materials for patient and/or GPs.' *^^^-^^ monitoring of prescribing behavior^'' and feedback,^''^^ and face-to-face physician instruction.-^" Additional measures fhat have been used in the hospital are re\ision and restriction of the antibiotic formulary, development of clinical pathways, and real-time streamlining.'"' Thus, current consensus favors the incorporation of behavior change modeis into educational interventions which should target not only the knowledge and attitudes of health care professionals but also that of the public"*" in conclusion, an educational intervention significantly decreased azithromycin consumption and overall economic expenditure in primary care military clinics. Interventions that focus on a selected antimicrobial agent may aid in achieving rapid restriction of use and substantial cost savings, but may adversely be associated with a trade-off effect. In light of the hierarchical nature of the military medical system, a focused educational intervention can be expected to be more efficacious than in civilian settings, but even in the military, suboptimal adherence of physicians to antimicrobial guidelines may occur. Future interventions should target physician prescribing behavior through a multifaceted approach to influence the culture of antibiotic prescribing.
